Food News and Research

RSS

Children who become overweight at young age continue to suffer later in life

The crucial importance of healthy eating in our formative years is the subject of a free University of Greenwich public lecture.

4 Mar 2014

Green tea can help combat colon cancer

Will a multi-generational exposure to a western type diet increase offspring's chance of developing colon cancer? Will cancer-fighting agents, like green tea, help combat that increased risk?

4 Mar 2014

Study shows SuperMum campaign improves handwashing behaviour

An analysis of a unique “SuperMum” handwashing campaign shows for the first time that using emotional motivators, such as feelings of disgust and nurture, rather than health messages, can result in significant, long-lasting improvements in people’s handwashing behaviour, and could in turn help to reduce the risk of infectious diseases.

4 Mar 2014

Nanomedicine – Past, Present and Future

News-Medical speaks to Frank Boehm about the fundamentals of nanomedicine and the nanotechnologies of the future.

4 Mar 2014

Potential climate change can disrupt food production in the Northeastern US

If significant climate change occurs in the United States it may be necessary to change where certain foods are produced in order to meet consumer demand.

4 Mar 2014

New federal standards increase consumption of fruits and vegetables

New federal standards launched in 2012 that require schools to offer healthier meals have led to increased fruit and vegetable consumption, according to a new study from Harvard School of Public Health (HSPH) researchers.

4 Mar 2014

Pre-moistened wipes linked to dramatic rise in allergic reactions, says dermatologist

More and more people are developing an itchy, painful rash in an effort to stay clean. A dermatologist at The Ohio State University Wexner Medical Center says a preservative in many types of pre-moistened wipes is linked to a dramatic rise in allergic reactions.

4 Mar 2014

Highlights: Fla. restaurant's health law surcharge; Fla. faces ER Medicaid fines; early-elective deliveries drop

A selection of health policy stories from Florida, California, the District of Columbia, Pennsylvania and Wisconsin.

4 Mar 2014

New minimally-invasive procedure to treat jackhammer esophagus

Six weeks ago 67-year old John Galbreath welcomed death, rather than live one more day. Intense pain in his chest had left him nearly bedridden for four months. Galbreath had a condition called jackhammer esophagus, which made him feel like the name suggests—like a jackhammer was going off in his chest.

4 Mar 2014

New approach to breast reconstruction surgery decreases use of postoperative opioid painkiller

A new approach to breast reconstruction surgery aimed at helping patients' bodies get back to normal more quickly cut their postoperative opioid painkiller use in half and meant a day less in the hospital on average, a Mayo Clinic study found.

4 Mar 2014

Viewpoints: Frightening seniors; regulating e-cigarettes; waiting for black lung drugs

The Obama administration's proposed cuts to Medicare Advantage plans - the private insurance plans that cover almost 30 percent of all Medicare beneficiaries - are fair and reasonable. As it happens, they are also mandated by law. Yet Republicans, sensing a campaign issue, are telling older and disabled Americans that the administration is "raiding Medicare Advantage to pay for Obamacare." The health insurance industry, for its part, is warning that enrollees will suffer higher premiums, lower benefits and fewer choices among doctors if the cuts go into force (3/1).

4 Mar 2014

ACC contradicts study linking prostate cancer to BPA exposure

The American Chemistry Council (ACC) offers the following comments regarding the study published today in PLOS ONE by the Cincinnati Cancer Center researchers Pheruza Tarapore, et al. Quotes from the following may be attributed to Steven G. Hentges, Ph.D. of ACC's Polycarbonate/BPA Global Group.

4 Mar 2014

Agilent Technologies launhces handheld FTIR spectrometer

Agilent Technologies Inc. today introduced a next-generation mobile spectroscopy product that is ideal for on-site testing in a broad range of applications, including advanced materials, art, historical objects, geology, agriculture, composites, coatings and polymers.

4 Mar 2014

Costly new hepatitis C drug raises questions about who will pay

The new hepatitis C medication presents a dilemma for Medicaid and other insurers, who must balance the cost against the large numbers of people who might benefit. A single course of treatment costs $84,000.

4 Mar 2014

Levels of bisphenol A in men's urine could be marker of prostate cancer

Findings by Cincinnati Cancer Center researchers show that levels of bisphenol A (BPA) in men's urine could be a marker of prostate cancer and that low levels of BPA exposure can cause cellular changes in both non-malignant and malignant prostate cells.

4 Mar 2014

Neuroscientists unlock a piece of puzzle in fight against Lou Gehrig's disease

Keck School of Medicine of USC neuroscientists have unlocked a piece of the puzzle in the fight against Lou Gehrig's disease, a debilitating neurological disorder that robs people of their motor skills.

4 Mar 2014

Naurex's GLYX-13 receives FDA Fast Track designation

Naurex Inc. today announced that the U.S. Food and Drug Administration has granted Fast Track designation to the investigation of GLYX-13, the company's rapid-acting antidepressant in Phase 2 clinical development, as adjunctive therapy in major depressive disorder.

4 Mar 2014

Research explores milk proteins for healthy aging and sports performance

The University of Limerick will take the lead in Phase 2 of Food for Health Ireland’s research programme to explore the role of milk proteins in healthy aging and performance nutrition.

4 Mar 2014

Acucela completes patient enrollment in Phase 2b/3 clinical trial of emixustat hydrochloride

Acucela Inc., a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases, today announced that it has completed enrollment in its ongoing Phase 2b/3 clinical trial investigating emixustat in subjects with geographic atrophy (GA) associated with dry age-related macular degeneration (AMD).

4 Mar 2014

First Edition: March 3, 2014

Today's headlins include stories detailing ongoing challenges with state-run exchanges as well as previews of what's next regarding the federal budget process.

3 Mar 2014